Genome-wide de novo risk score implicates promoter variation in autism spectrum disorder
- Authors
- 안준용
- Issue Date
- Dec-2018
- Publisher
- AMER ASSOC ADVANCEMENT SCIENCE
- Citation
- SCIENCE, v.362, no.6420, pp.1270 - 1270
- Indexed
- SCIE
SCOPUS
- Journal Title
- SCIENCE
- Volume
- 362
- Number
- 6420
- Start Page
- 1270
- End Page
- 1270
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/139710
- ISSN
- 0036-8075
- Abstract
- Whole-genome sequencing (WGS) has facilitated the first genome-wide evaluations of the contribution of de novo noncoding mutations to complex disorders. Using WGS, we identified 255,106 de novo mutations among sample genomes from members of 1902 quartet families in which one child, but not a sibling or their parents, was affected by autism spectrum disorder (ASD). In contrast to coding mutations, no noncoding functional annotation category, analyzed in isolation, was significantly associated with ASD. Casting noncoding variation in the context of a de novo risk score across multiple annotation categories, however, did demonstrate association with mutations localized to promoter regions. We found that the strongest driver of this promoter signal emanates from evolutionarily conserved transcription factor binding sites distal to the transcription start site. These data suggest that de novo mutations in promoter regions, characterized by evolutionary and functional signatures, contribute to ASD.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Health Sciences > School of Biosystems and Biomedical Sciences > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.